<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-molecules-24-02603">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wu</surname>
    <given-names>V.H.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Masoum</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Raugi</surname>
    <given-names>D.N.</given-names>
   </name>
   <name>
    <surname>Ba</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Seydi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Grobler</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Gottlieb</surname>
    <given-names>G.S.</given-names>
   </name>
  </person-group>
  <article-title>MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine) exhibits potent activity against HIV-2 isolates and drug-resistant HIV-2 mutants in culture</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2017</year>
  <volume>61</volume>
  <fpage>e00744-17</fpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00744-17</pub-id>
  <pub-id pub-id-type="pmid">28559249</pub-id>
 </element-citation>
</ref>
